Table 2.
Comparison of laboratory parameters on admission between the COVID-19 and non-COVID-19 groups.
| Variables | Total (n = 218) | COVID-19 (n = 96) | Non-COVID-19 (n = 122) | P value | |
|---|---|---|---|---|---|
| Leukocyte count (109/L) | 6.1 (4.5–8.9) | 5.7 (4.1–10.1) | 6.3 (5.0–8.6) | 0.756 | |
| Neutrophil (109/L) | 4.1 (2.8–6.9) | 4.4 (2.8–8.4) | 3.9 (2.8–5.8) | 0.068 | |
| Lymphocyte (109/L) | 1.1 (0.7–1.6) | 0.8 (0.5–1.2) | 1.4 (1.0–1.9) | <0.001 | |
| Monocyte (109/L) | 0.47 (0.30–0.66) | 0.34 (0.23–0.54) | 0.51 (0.38–0.76) | <0.001 | |
| Eosinophil (109/L) | 0.01 (0.00–0.07) | 0.00 (0.00–0.01) | 0.04 (0.01–0.10) | <0.001 | |
| Hemoglobin (g/L) | 135.57 ± 24.39 | 131.97 ± 21.04 | 138.39 ± 26.48 | 0.054 | |
| Platelet count (109/L) | 203 (163–256) | 193 (156–243) | 215 (172–266) | 0.066 | |
| Serum bilirubin (µmol/l) | 10.5 (6.8–13.9) | 11.1 (7.9–15.9) | 10.0 (6.2–13.5) | 0.061 | |
| AST (U/L) | 20 (16–30) | 22 (17–36) | 18 (15–25) | 0.003 | |
| ALT (U/L) | 19 (13–28) | 21 (14–37) | 16 (12–27) | 0.007 | |
| Creatinine (μmol/L) | 72 (58–84) | 72 (60–88) | 70 (57–83) | 0.244 | |
| eGFR (ml/min) | 97 (84–112) | 94 (74–107) | 100 (87–114) | 0.008 | |
| Serum potassium (mmol/L) | 4.0 (3.7–4.4) | 3.94 (3.60–4.27) | 4.10 (3.81–4.37) | 0.011 | |
| CK (U/L) | 69 (43–101) | 66 (40–110) | 72 (48–99) | 0.787 | |
| LDH (U/L) | 205 (163–277) | 260 (211–340) | 176 (152–212) | <0.001 | |
| INR | 0.98 (0.94–1.03) | 0.98 (0.94–1.03) | 0.98 (0.93–1.04) | 0.884 | |
| CRP (mg/L) | 14.8 (2.5–44.1) | 21.3 (8.8–51.2) | 9.1 (1.0–26.2) | <0.001 | |
| Procalcitonin (ng/mL) | 0.05 (0.03–0.1) | 0.06 (0.03–0.09) | 0.05 (0.03–0.11) | 0.404 | |
Data are expressed as mean ± standard deviation and median (Q1–Q3). Comparisons between groups were performed by Student's t-test and Mann–Whitney's U test. ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: blood urea; CK: creatine kinase; CRP: C-reactive protein; eGFR: estimated glomerular filtration rate; INR: international normalized ratio; LDH: lactate dehydrogenase.